Structural and Chemical Biology Department. Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
Laboratory of Biomolecular Research, Division of Biology and Chemistry, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland.
Int J Mol Sci. 2019 Mar 20;20(6):1392. doi: 10.3390/ijms20061392.
It has been proposed that one of the mechanisms of taxane-site ligand-mediated tubulin activation is modulation of the structure of a switch element (the M-loop) from a disordered form in dimeric tubulin to a folded helical structure in microtubules. Here, we used covalent taxane-site ligands, including cyclostreptin, to gain further insight into this mechanism. The crystal structure of cyclostreptin-bound tubulin reveals covalent binding to βHis229, but no stabilization of the M-loop. The capacity of cyclostreptin to induce microtubule assembly compared to other covalent taxane-site agents demonstrates that the induction of tubulin assembly is not strictly dependent on M-loop stabilization. We further demonstrate that most covalent taxane-site ligands are able to partially overcome drug resistance mediated by βIII-tubulin (βIII) overexpression in HeLa cells, and compare their activities to pironetin, an interfacial covalent inhibitor of tubulin assembly that displays invariant growth inhibition in these cells. Our findings suggest a relationship between a diminished interaction of taxane-site ligands with βIII-tubulin and βIII tubulin-mediated drug resistance. This supports the idea that overexpression of βIII increases microtubule dynamicity by counteracting the enhanced microtubule stability promoted by covalent taxane-site binding ligands.
有人提出,紫杉烷结合位点配体介导的微管蛋白激活的机制之一是调节开关元件(M 环)的结构,从二聚体微管蛋白中的无序形式转变为微管中的折叠螺旋结构。在这里,我们使用共价紫杉烷结合配体,包括环丝氨酸肽,来进一步深入了解这一机制。环丝氨酸肽结合的微管蛋白的晶体结构揭示了与 βHis229 的共价结合,但没有稳定 M 环。与其他共价紫杉烷结合剂相比,环丝氨酸肽诱导微管组装的能力表明,微管蛋白组装的诱导并不严格依赖于 M 环的稳定。我们进一步证明,大多数共价紫杉烷结合配体能够部分克服 HeLa 细胞中βIII-微管蛋白(βIII)过表达介导的药物耐药性,并将它们的活性与 pironetin 进行比较,pironetin 是一种界面共价抑制剂,对这些细胞中的微管蛋白组装具有不变的生长抑制作用。我们的研究结果表明,紫杉烷结合位点配体与βIII-微管蛋白相互作用减弱与βIII 微管蛋白介导的药物耐药性之间存在关系。这支持了这样一种观点,即βIII 的过表达通过抵消共价紫杉烷结合配体促进的增强的微管稳定性,增加微管的动态性。